Elutia Inc.
Elutia Inc., a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation and breast reconstruction in the United States. It operates in three segments: Device Protection, Women's Health, and Cardiovascular. The company offers EluPro, which is used to accommodate cardiac implantable electronic devices, such as pacemakers and internal defibrillators;… Read more
Elutia Inc. (ELUT) - Total Assets
Latest total assets as of September 2025: $29.41 Million USD
Based on the latest financial reports, Elutia Inc. (ELUT) holds total assets worth $29.41 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Elutia Inc. - Total Assets Trend (2018–2024)
This chart illustrates how Elutia Inc.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Elutia Inc. - Asset Composition Analysis
Current Asset Composition (December 2024)
Elutia Inc.'s total assets of $29.41 Million consist of 72.4% current assets and 27.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 36.7% |
| Accounts Receivable | $7.04 Million | 19.5% |
| Inventory | $3.91 Million | 10.8% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $8.27 Million | 22.9% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2018–2024)
This chart illustrates how Elutia Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Elutia Inc.'s current assets represent 72.4% of total assets in 2024, an increase from 38.0% in 2018.
- Cash Position: Cash and equivalents constituted 36.7% of total assets in 2024, up from 5.1% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 22.0% of total assets, an increase from 0.0% in 2018.
- Asset Diversification: The largest asset category is intangible assets at 22.9% of total assets.
Elutia Inc. Competitors by Total Assets
Key competitors of Elutia Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Elutia Inc. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Elutia Inc. generates 0.67x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Elutia Inc. is currently not profitable relative to its asset base.
Elutia Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.44 | 0.94 | 1.74 |
| Quick Ratio | 0.40 | 0.85 | 1.31 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-22.96 Million | $ -2.36 Million | $ 16.74 Million |
Elutia Inc. - Advanced Valuation Insights
This section examines the relationship between Elutia Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.74 |
| Asset Growth Rate (YoY) | -16.8% |
| Total Assets | $36.13 Million |
| Market Capitalization | $26.88 Million USD |
Valuation Analysis
Below Book Valuation: The market values Elutia Inc.'s assets below their book value (0.74 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Elutia Inc.'s assets decreased by 16.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Elutia Inc. (2018–2024)
The table below shows the annual total assets of Elutia Inc. from 2018 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $36.13 Million | -16.81% |
| 2023-12-31 | $43.43 Million | -36.92% |
| 2022-12-31 | $68.84 Million | +2.49% |
| 2021-12-31 | $67.17 Million | -18.89% |
| 2020-12-31 | $82.81 Million | +84.96% |
| 2019-12-31 | $44.77 Million | -6.22% |
| 2018-12-31 | $47.74 Million | -- |